The immunotherapy used in the trial was nivolumab ( Opdivo ), a drug delivered intravenously that works by disabling a ...

Despite the death of its golden goose, AbbVie expects to achieve high single-digit compound annual sales growth to the end of ...

Immunotherapeutics have transformed cancer outcomes. It is crucial that response patterns seen with them are assessed ...

The "personalized cancer vaccines" (PCVs) used by the nine patients in the trial were targeted to genes specific to their ...

Tevogen Bio is driven by a team of highly experienced industry leaders and distinguished scientists with drug development and global product launch experience. Tevogen Bio’s leadership believes that ...

Lung metastasis (from metastatic breast cancer) resolved - after only 2 months (4 doses) of treatment with Bria-OTS™ ...

The company forecast 2025 revenue of around $45.5 billion, down from $48.3 billion in 2024 and below analyst expectations of $47.4 billion, according to LSEG data. It forecast 2025 earnings in the ...

BioNTech SE operates as immunotherapy company, which engages therapies for cancer and other serious diseases. Its product pipeline include BNT162b2, BNT161, BNT164, FixVac, iNeST, RiboMabs ...

A mum-of-two described as the "most caring and beautiful soul" has been diagnosed with stage four cancer. Jess Hopkinson, 35, initially went to the doctors after experiencing bleeding and lower back ...

A groundbreaking study has delivered "exciting" findings, indicating that a new cancer vaccine could be on the verge of ...

You are braver than you believe, stronger than you seem, smarter than you think, and twice as beautiful as you’d ever imagined. Cancer remains one of the most formidable health challenges ...